SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-070700
Filing Date
2024-08-19
Accepted
2024-08-19 16:16:12
Documents
71
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0211509-10q_aditxtinc.htm   iXBRL 10-Q 1750389
2 AMENDMENT NO. 1 TO AMENDED AND RESTATED MERGER AGREEMENT ea021150901ex2-1_aditxtinc.htm EX-2.1 13928
3 CERTIFICATION ea021150901ex31-1_aditxtinc.htm EX-31.1 11456
4 CERTIFICATION ea021150901ex31-2_aditxtinc.htm EX-31.2 11332
5 CERTIFICATION ea021150901ex32-1_aditxtinc.htm EX-32.1 5169
  Complete submission text file 0001213900-24-070700.txt   9692676

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE adtx-20240630.xsd EX-101.SCH 86047
7 XBRL CALCULATION FILE adtx-20240630_cal.xml EX-101.CAL 37418
8 XBRL DEFINITION FILE adtx-20240630_def.xml EX-101.DEF 461025
9 XBRL LABEL FILE adtx-20240630_lab.xml EX-101.LAB 756457
10 XBRL PRESENTATION FILE adtx-20240630_pre.xml EX-101.PRE 460736
74 EXTRACTED XBRL INSTANCE DOCUMENT ea0211509-10q_aditxtinc_htm.xml XML 985878
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39336 | Film No.: 241220745
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)